NDC product
Sinufrin Decongestant
NDC 13709-355 · NeilMed Pharmaceuticals Inc
Key facts
| Product NDC | 13709-355 |
|---|---|
| Proprietary name | Sinufrin Decongestant |
| Nonproprietary name | Nasal Congestion Relief |
| Substances | OXYMETAZOLINE HYDROCHLORIDE |
| Dosage form | SOLUTION |
| Route | NASAL |
| Labeler | NeilMed Pharmaceuticals Inc |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC] |
| Marketing start | May 25, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: